MB
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Impact des médicaments de la douleur sur le psychisme et la vie émotionnelle : une réflexion pour guider la prescription | Douleur et analgésie | 2025 | 3 | 0 | |||
| Antipsychotic medication for behaviors that challenge in individuals with intellectual disabilities: a clinically informed review | Frontiers in psychiatry | 2025 | 31 | 629 | |||
| Prise en charge de la douleur aiguë en ambulatoire | Revue médicale suisse | 2024 | 82 | 0 | |||
| 50 ans de l’IASP : une revue de la vitalité des recherches sur la douleur et des contributions francophones | Douleur et analgésie | 2024 | 3 | 0 | |||
| Alliance thérapeutique et thérapie cognitivo-comportementale de groupe | Revue médicale suisse | 2023 | 114 | 396 | |||
| De nouvelles perspectives pour Douleur et Analgésie | Douleur et analgésie | 2023 | 2 | 0 | |||
| Thérapie cognitive-comportementale de groupe : quelques éléments cliniques autour des concepts de honte et de culpabilité chez les patients souffrant de douleurs chroniques | Douleur et analgésie | 2023 | 6 | 0 | |||
| Quand la discontinuation des psychotropes s’impose : manifestations cliniques et approche thérapeutique | Revue médicale suisse | 2022 | 246 | 272 | |||
| Hydromorphone Prescription for Pain in Children - What Place in Clinical Practice? | Frontiers in pediatrics | 2022 | 187 | 244 | |||
| Douleur et troubles du sommeil | Douleur et analgésie | 2022 | 7 | 0 | |||
| À propos de l’utilisation du traitement de la kétamine aux urgences psychiatriques | Revue médicale suisse | 2021 | 439 | 620 | |||
| Activité, décentration et restructuration cognitive dans la thérapie cognitivocomportementale. Éléments pour la pratique clinique | Revue médicale suisse | 2021 | 398 | 1,574 | |||
| Antibiomania: a case report of clarithromycin and amoxicillin-clavulanic acid induced manic episodes separately | BMC psychiatry | 2021 | 488 | 284 | |||
| CYP450 Genotype-Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting | Frontiers in pharmacology | 2021 | 286 | 367 | |||
| Prevalence of Polypharmacy and Inappropriate Medication in Adults With Intellectual Disabilities in a Hospital Setting in Switzerland | Frontiers in Psychiatry | 2021 | 321 | 559 | |||
| Gabapentinoids: The rise of a new misuse epidemics? | Psychiatry research | 2021 | 242 | 518 | |||
| Cannabinoids and COVID-19 | Medical Cannabis and Cannabinoids | 2020 | 260 | 236 | |||
| Mise au point sur la prise en charge de la douleur chez les patients adultes atteints de déficience intellectuelle | Douleur et analgésie | 2020 | 66 | 2 | |||
| GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteers | European Journal of Pain | 2020 | 265 | 1 | |||
| Opioïdes chez les patients âgés: Faux-amis ? | La gazette médicale - info@gériatrie | 2020 | 257 | 1 | |||
| Crise suicidaire et prévention du suicide : aspects psychopharmacologiques | Revue médicale suisse | 2020 | 622 | 698 | |||
| Antidépresseurs dans la douleur chronique : pourquoi les utiliser, comment les prescrire en pratique ? | Revue médicale suisse | 2020 | 506 | 3 | |||
| Pain interventions in adults with intellectual disability: A scoping review and pharmacological considerations | European Journal of Pain | 2020 | 295 | 2 | |||
| TOP-ID: a Delphi technique-guided development of a prescription and deprescription tool for adults with intellectual disabilities | BMJ Open | 2020 | 383 | 165 | |||
| Gestion médicamenteuse des troubles du comportement de la personne en situation de handicap mental | Revue médicale suisse | 2020 | 402 | 417 | |||
| Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective Study | Journal of Personalized Medicine | 2020 | 359 | 131 | |||
| A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorder | BMC Psychiatry | 2019 | 525 | 1,709 | |||
| Psychotropes et perturbation des tests hépatiques : conduite à tenir | Revue médicale suisse | 2018 | 445 | 2 | |||
| Phenotypic Assessment of Drug Metabolic Pathways and P-Glycoprotein in Patients Treated With Antidepressants in an Ambulatory Setting | Journal of Clinical Psychiatry | 2018 | 493 | 0 | |||
| Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study) | BMC Pharmacology & Toxicology | 2017 | 523 | 223 | |||
| Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective study | Pharmacological research | 2017 | 665 | 195 | |||
| PIM-Check: development of an international prescription-screening checklist designed by a Delphi method for internal medicine patients | BMJ Open | 2017 | 776 | 522 | |||
| Le coût, ce n'est pas tout…à propos des médicaments génériques | Revue médicale suisse | 2016 | 457 | 3 | |||
| The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesia | Neuropharmacology | 2016 | 600 | 342 | |||
| Topiramate-induced severe heatstroke in an adult patient: a case report | Journal of medical case reports | 2016 | 523 | 351 | |||
| Markers of Individual Drug Metabolism: Towards the Development of a Personalized Antidepressant Prescription | Current drug metabolism | 2015 | 589 | 3 | |||
| Prescribing Generic Medication in Chronic Musculoskeletal Pain Patients: An Issue of Representations, Trust, and Experience in a Swiss Cohort | PloS one | 2015 | 603 | 318 | |||
| Providing Quality Therapeutics in Switzerland: Role of the Stakeholders and Recent Incentives for Further Improvements | Clinical therapeutics | 2015 | 721 | 6 | |||
| Douleur et sensibilisation centrale : implication des voies GABAergiques et intérêt de leur modulation | 2015 | 2,088 | 19 | ||||
| Baclofen-Associated Onset of Central Sleep Apnea in Alcohol Use Disorder: A Case Report | Respiration | 2015 | 647 | 0 | |||
| Prescription d'antidépresseurs dans le traitement de la douleur : rôle de la pharmacogénétique | Revue médicale suisse | 2015 | 572 | 1 | |||
| Electrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness Analysis | PloS one | 2015 | 527 | 367 | |||
| GABAergic modulation in central sensitization in humans: a randomized placebo-controlled pharmacokinetic-pharmacodynamic study comparing clobazam with clonazepam in healthy volunteers | Pain | 2015 | 629 | 3 | |||
| Central Pain Sensitization, COMT Val158Met Polymorphism, and Emotional Factors in Fibromyalgia | The journal of pain | 2014 | 740 | 2 | |||
| Antihyperalgesic Effect of the GABA(A) Ligand Clobazam in a Neuropathic Pain Model in Mice: A Pharmacokinetic-Pharmacodynamic Study | Basic & clinical pharmacology & toxicology | 2013 | 651 | 462 | |||
| Reversible ventricular arrythmia induced by dasatinib | Clinical case reports | 2013 | 659 | 251 | |||
| Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trial | Pain physician | 2013 | 630 | 1,155 | |||
| Evaluation of anti-hyperalgesic and analgesic effects of two benzodiazepines in human experimental pain: a randomized placebo-controlled study | PloS one | 2013 | 664 | 484 | |||
| Validation of the simplified UVB model to assess the pharmacodynamics of analgesics in healthy human volunteers | Chimia | 2012 | 809 | 1,183 | |||
| Analgesics in patients with hepatic impairment: pharmacology and clinical implications | Drugs | 2012 | 709 | 3 | |||
| A randomized, controlled trial validates a peripheral supra-additive antihyperalgesic effect of a paracetamol-ketorolac combination | Basic & clinical pharmacology & toxicology | 2011 | 682 | 0 | |||
| HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain | Neuropharmacology | 2011 | 822 | 710 | |||
| Naloxone-responsive acute dystonia and parkinsonism following general anaesthesia | Anaesthesia | 2009 | 667 | 0 | |||
| Two-dimensional liquid chromatography-ion trap mass spectrometry for the simultaneous determination of ketorolac enantiomers and paracetamol in human plasma: application to a pharmacokinetic study | Journal of chromatography | 2009 | 566 | 0 | |||
| Homotopic stimulation can reduce the area of allodynia in patients with neuropathic pain | European journal of pain | 2009 | 652 | 0 | |||
| Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteers | Drug metabolism letters | 2008 | 864 | 0 | |||
| New approaches to the pharmacotherapy of neuropathic pain | Expert review of clinical pharmacology | 2008 | 590 | 0 | |||
| Analgésie et insuffisance rénale | Revue médicale suisse | 2008 | 711 | 607 | |||
| La prescription « off-label » | Revue médicale suisse | 2008 | 700 | 0 | |||
| Prise en charge médicamenteuse de la douleur neuropathique : quelle place pour les traitements topiques? | Revue médicale suisse | 2008 | 430 | 0 | |||
| Automédication chez les sans-papiers latino-américains : entre le nécessaire et l'inapproprié | Revue médicale suisse | 2007 | 425 | 0 | |||
| Genre et douleur : influence du cycle menstruel sur le seuil expérimental d'apparition de la douleur | 2004 | 1,552 | 1,567 |
